Fanconi Anemia Clinical Trials

78 clinical trials for Fanconi Anemia across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia — RECRUITING
• Cancer in Inherited Bone Marrow Failure Syndromes — RECRUITING
• Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia — RECRUITING
• Role of Acetaldehyde in the Development of Oral Cancer — RECRUITING · NA
• MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients — RECRUITING
• FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector — RECRUITING · NA
• Familial Investigations of Childhood Cancer Predisposition — RECRUITING
• Investigation of the Genetics of Hematologic Diseases — RECRUITING
• Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) — RECRUITING · PHASE1
• A web-based psychosocial support program for families with Li-Fraumeni Syndrome or Fanconi Anemia: A brief feasibility study protocol — RECRUITING
• Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102 — RECRUITING
• Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders — RECRUITING · PHASE2
• Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab — RECRUITING · PHASE1
• Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures — RECRUITING · PHASE2
• HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy — RECRUITING · PHASE2
• Psychosocial support needs of families with Li-Fraumeni syndrome (LFS) or Fanconi anaemia (FA) — RECRUITING
• Clinical Genetics Branch Eligibility Screening Survey — NOT_YET_RECRUITING
• Prenatal Transplantation for Fetuses With Fanconi Anemia — NOT_YET_RECRUITING · PHASE1
• Translational Research for Persons with Abnormal DNA Damage Response — OTHER
• Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia — COMPLETED · PHASE2
• Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy — ACTIVE_NOT_RECRUITING
• Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of autologous CD34+ cells transduced with a lentiviral vector carrying the FANCA gene (orphan drug) in patients with Fanconi Anaemia Subtype A: FANCOLEN-I — TERMINATED · PHASE2
• Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer — ACTIVE_NOT_RECRUITING · NA
• Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts — OTHER
• Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor — COMPLETED · PHASE1
• Eltrombopag for People With Fanconi Anemia — ACTIVE_NOT_RECRUITING · PHASE2
• Baby Detect : Genomic Newborn Screening — COMPLETED
• Corrective Exercise and Rehabilitation in Fanconi Anemia: A Case Study — COMPLETED · NA
• A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia — WITHDRAWN · PHASE1
• Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases — COMPLETED · PHASE2
• Safety and Efficacy of Metformin for Treatment of Cytopenia in Children and Adolescents With Fanconi Anemia — OTHER · PHASE3
• Time-restricted Feeding to Reduce Inflammation in Fanconi Anemia — COMPLETED · NA
• Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia — COMPLETED
• Gene Therapy for Fanconi Anemia — TERMINATED · PHASE1
• Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia — TERMINATED
• Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A — COMPLETED · PHASE1
• Quercetin in Children With Fanconi Anemia; a Pilot Study — COMPLETED · PHASE1
• Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant — TERMINATED · PHASE1
• Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study — TERMINATED · PHASE1
• Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients — COMPLETED
• Eltrombopag for Treatment of Fanconi Anemia — COMPLETED · PHASE2
• Microcephaly, Fanconi Anemia and Praxial Disorders — WITHDRAWN · NA
• Pilot Study of Metformin for Patients With Fanconi Anemia — COMPLETED · PHASE2
• Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma — COMPLETED
• A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia — TERMINATED · PHASE2
• Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia — COMPLETED · PHASE2
• TBI Dose De-escalation for Fanconi Anemia — COMPLETED · PHASE2
• Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia — COMPLETED · PHASE1
• Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation — COMPLETED
• Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 — COMPLETED · PHASE1

Refine this search